HDAC9 and cancer: Vorinostat and other HDAC inhibitors have shown synergistic or additive antitumor effects with a wide range of cancer treatment modalities, including chemotherapy, molecularly targeted therapy, and radiation therapy, by various mechanisms, some unique for particular combinations [28].